Divis Laboratories Ltd.
9,023.00-262.0 (-2.82%)
14 Oct, 12:00 AM
Stock News
Divis Laboratories Ltd. latest news covering earnings updates, regulatory announcements, analyst actions and market-moving events.
Economic Times
Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stock
Jefferies assigned a Buy rating to Divi's Laboratories with a target price of Rs 10,200, projecting 22% EPS CAGR over FY26-29. Jefferies said Divi's Laboratories leads peers with an estimated 80% of CRDMO sales from non-biotech customers, $103.5 billion in associated end-market sales, Rs 111 billion gross block and 16,500 kilolitres of small-molecule capacity.
13th Oct '26 4:40 am
Read full article on economictimes.indiatimes.com